Allervarx

Natural health product licensed in Canada

Licence holder: Innovus Pharmaceuticals, Inc.
NPN or DIN-HM: 80082649
Status: Inactive licence
Licence date: 24 January 2018
Revision date: 17 August 2022
Form: Capsule
Route of administration: Orale
Application type: Non traditionnelle

If this product were sold in France

Dose déclarée au-delà d'une limite
Vitamine D: up to 10 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
Conditions légales
Perilla frutescens (L.) Britton: Seule l'utilisation du chemotype aldéhyde est autorisée
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source	Maximum per day, adult
Vitamine D Source : Cholécalciférol	5 mcg	10 µg
3,3',4',5,7-Pentahydroxyflavone Source : Styphnolobium japonicum - Bourgeon floral	150 mg	Not calculated
3,3',4',5,7-Pentahydroxyflavone Source : Quercétine dihydraté	150 mg	Not calculated
Perilla frutescens Source : Feuille Extract : Matériel brut sec Extraction ratio : 15:1 Dry plant equivalent : 1,200 mg Potency : 12 % Rosmarinic acid	80 mg	Not calculated
Arthrospira platensis Source : En entier	1 g	Not calculated

Non-medicinal ingredients

Cire de Carnauba, Dioxyde de silicium, Croscarmellose de sodium, Talc, Maltodextrine, Cellulose microcristalline, Stéarate de magnésium, Acide stéarique, Éthylcellulose

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes	Not specified	1 Capsule	2 days

Uses authorised in Canada

Text supplied in English because no French text is available.

An antioxidant. Helps reduce nasal and/or eye symptoms in subjects with seasonal allergic rhinitis. Helps in the development and maintenance of bones and teeth. Helps in the absorption and use of calcium and phosphorus. Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis. Helps to prevent vitamin D deficiency. Helps reduce symptoms of allergic rhinitis such as nasal discharge, sneezing, nasal congestion and itching.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80082649

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated 17 August 2022 (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging